Precipio Inc (NASDAQ:PRPO) shares dropped 6.7% on Friday . The stock traded as low as $0.27 and last traded at $0.28. Approximately 980,816 shares traded hands during trading, a decline of 12% from the average daily volume of 1,114,479 shares. The stock had previously closed at $0.30.
The company has a current ratio of 0.12, a quick ratio of 0.11 and a debt-to-equity ratio of 0.23.
Precipio (NASDAQ:PRPO) last announced its earnings results on Thursday, August 23rd. The biotechnology company reported ($0.15) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.93 by ($2.08). The business had revenue of $0.82 million for the quarter. Precipio had a negative return on equity of 163.27% and a negative net margin of 904.42%.
ILLEGAL ACTIVITY NOTICE: “Precipio (PRPO) Stock Price Down 6.7%” was originally reported by WKRB News and is owned by of WKRB News. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://www.wkrb13.com/2018/11/17/precipio-prpo-stock-price-down-6-7.html.
Precipio, Inc, a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment.
Featured Story: How to Invest in Marijuana Stocks
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.